Press release
Keytruda: A Leading Driver Behind The Rising Prevalence Of Cancer Driving Growth In The Keytruda Market Market Expansion in 2025
Keytruda Market
What Will the Keytruda Industry Market Size Be by 2025?
The Keytruda market has witnessed a significant expansion in its size over the past few years. It is projected to escalate from $21.6 billion in 2024 to $23.8 billion in 2025, marking a compound annual growth rate (CAGR) of 10.2%. Factors contributing to this growth during the historic period include enhanced patient results, wide-ranging acceptance of immunotherapy, advancements in research and development, better patient adherence, and a surge in the adoption of Keytruda.
What's the Long-Term Growth Forecast for the Keytruda Market Size Through 2029?
Expectations for the Keytruda market size forecasts a robust expansion in the coming years. The market is projected to reach a value of $34.61 billion in the year 2029, growing with a CAGR of 9.8%. The anticipated growth during the forecasted period is accredited to the expansion of indications, the advent of new markets, increased cancer prevalence, a surge in healthcare spending, and the rising demand for precision medicine. Several trends could be seen during this forecast period, including the increased demand for targeted therapies, progress in immunotherapy and diagnostic technologies, increased need for cancer treatment, and advancements in cancer-related research.
View the full report here:
https://www.thebusinessresearchcompany.com/report/keytruda-global-market-report
What Are the Key Growth Drivers Fueling the Keytruda Market Expansion?
The keytruda market is being bolstered by the escalating incidence of cancer. Cancer, typified by erratic cell growth and propagation, is a multifaceted cluster of diseases. Its spread is attributed to genetic components, lifestyle choices, environmental influences, and hormonal aspects. Keytruda (pembrolizumab) enhances cancer management by empowering the body's immune system to combat cancer cells more efficiently. It epitomizes a significant development in cancer management, leveraging the capabilities of the immune system to focus on and eliminate cancer cells, offering renewed optimism for many individuals with late-stage or metastasized cancers. For instance, data from the American Cancer Society, a US nonprofit committed to cancer advocacy, indicated an increase in cancer cases to 2,001,140 in January 2024, from 1,958,310 in 2023, recording a growth of 2.19%. Hence, the escalating incidence of cancer fuels the growth of the keytruda market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16457&type=smp
What Are the Key Trends Driving Keytruda Market Growth?
Leading firms in the Keytruda market such as Merck are launching novel products like pembrolizumab to broaden the range of treatment solutions. Pembrolizumab is a monoclonal antibody medicine, part of the immune checkpoint inhibitors drug category. Marketed under Keytruda brand, it targets and obstructs the function of a protein known as PD-1 (programmed cell death protein 1) on T immune cells. For example, in November 2023, Merck, a renowned US-based Keytruda manufacturer, introduced KEYTRUDA (pembrolizumab) used in concurrence with fluoropyrimidine- and platinum-inclusive chemotherapy, sanctioned by the US-based government entity, the Food and Drug Administration. This combination showcases remarkable improvements in terms of overall duration of survival and period of disease stability, compared to sole chemotherapy, thus depicting a significant development in gastric cancer treatment. In various clinical trials, this amalgamated therapy depicted advancements in overall survival (OS), period of disease stability (PFS), and the overall response rate (ORR) compared to using chemotherapy independently.
How Is the Keytruda Market Segmented?
The keytruda market covered in this report is segmented -
1) By Cancer Type: Melanoma, Lung Cancer, Head And Neck Cancer, Hodgkin Lymphoma, Stomach Cancer, Urothelial Carcinoma
2) By Payer Type: Commercial, Medicare, Medicaid
3) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies
Subsegments:
1) By Melanoma: Advanced Or Unresectable Melanoma, Adjuvant Treatment For Melanoma
2) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)
3) By Head And Neck Cancer: Squamous Cell Carcinoma Of The Head And Neck (SCCHN), Recurrent Or Metastatic Head And Neck Cancer
4) By Hodgkin Lymphoma: Classical Hodgkin Lymphoma, Relapsed Or Refractory Hodgkin Lymphoma
5) By Stomach Cancer: Advanced Or Metastatic Gastric Cancer, Esophagogastric Junction Cancer
6) By Urothelial Carcinoma: Advanced Or Metastatic Urothelial Carcinoma, Muscle-Invasive Bladder Cancer
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16457&type=smp
Which Companies Are Leading the Charge in Keytruda Market Innovation?
Major companies operating in the keytruda market are Pfizer Inc., Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Novartis AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., Chugai Pharmaceutical Co. Ltd., BioNTech AG, Organon Co., Ono Pharmaceutical Co. Ltd., Samsung Bioepis Co. Ltd., Fate Therapeutics Inc., Merck Sharp & Dohme Corp., KinBio, Schering-Plough AB, LGM Pharma LLC, Gritstone Bio Inc.
Which Regions Are Leading the Global Keytruda Market in Revenue?
North America was the largest region in the keytruda market in 2023. The regions covered in the keytruda market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16457
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Keytruda: A Leading Driver Behind The Rising Prevalence Of Cancer Driving Growth In The Keytruda Market Market Expansion in 2025 here
News-ID: 4136239 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Key
Mobile Office Market Size, Share and Forecast By Key Players-Key Player I, Key P …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Mobile Office market is anticipated to grow at a compound annual growth rate (CAGR) of 15.39% between 2024 and 2031. The market is expected to grow to USD 8.1 Billion by 2024. The valuation is expected to reach USD 22.04 Billion by 2031.
With more people seeking flexible work arrangements, the market for mobile offices is expanding significantly. Businesses are embracing mobile…
Olivine Sand Market Size, Share and Forecast By Key Players-Key Player I, Key Pl …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Olivine Sand market is anticipated to grow at a compound annual growth rate (CAGR) of 16.07% between 2024 and 2031. The market is expected to grow to USD 39 Billion by 2024. The valuation is expected to reach USD 110.69 Billion by 2031.
The olivine sand market is poised for significant growth due to its increasing use in…
Excimer Lamps Market Size, Share and Forecast By Key Players-Key Player I, Key P …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Excimer Lamps market is anticipated to grow at a compound annual growth rate (CAGR) of 8.46% between 2024 and 2031. The market is expected to grow to USD 11.09 Billion by 2024. The valuation is expected to reach USD 19.58 Billion by 2031.
The need for excimer lamps is rising significantly across a number of industries, including semiconductor manufacturing, healthcare, and environmental…
4-Tert-Butyl Benzaldehyde Market Size, Trends 2031 By Key Players- Key Player I, …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Reports analysis, the global 4-Tert-Butyl Benzaldehyde Market size was valued at USD 100 Million in 2023 and is expected to reach USD 140.5Million by the end of 2031 with a CAGR of 5.7% during the forecast period 2024-2031.
The 4-Tert-Butyl Benzaldehyde Market presents significant opportunities for growth driven by various factors. One key opportunity lies in the expanding applications of 4-tert-butyl benzaldehyde as a…
Tri N pentylamine Market Size, Potential Scope 2031 By Key Players- Key Player I …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Reports analysis, the global Tri N pentylamine Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a 𝐂𝐀𝐆𝐑 𝐗𝐗.𝐗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟏.
The Tri N pentylamine Market presents notable opportunities for growth driven by various factors. One significant opportunity lies in the increasing demand for tri N pentylamine as a…
Isobutyl Benzene (IBB) Market Size, Insights 2031 by Key Vendors- Key Player I, …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Reports analysis, the global Isobutyl Benzene (IBB) Market size was valued at USD 18.2 Million in 2023 and is expected to reach USD 25.4 Million by the end of 2031 with a CAGR of 5.15% During the Forecast Period 2024-2031.
The Isobutyl Benzene (IBB) market presents promising opportunities driven by its versatile applications across various industries, including chemicals, pharmaceuticals, and plastics. Isobutyl benzene is…
